PulseAugur
EN
LIVE 09:48:21
中文(ZH) 甲骨文CFO:预计2027财年资本净支出为700亿美元,投资回报具备充分保障

Oracle plans $70B capex; HKEX lists 90 biotech & 10 tech firms

Oracle's CFO announced that the company anticipates $70 billion in net capital expenditures for fiscal year 2027, with returns secured by long-term customer contracts. Separately, Hong Kong Stock Exchange data shows 90 biotech companies listed under Chapter 18A since 2018, raising over 142.9 billion Hong Kong dollars. The exchange's Chapter 18C, for specialized tech firms, has seen 10 companies list in the first five months of 2026, primarily in AI, robotics, and autonomous driving. AI

IMPACT Oracle's significant capital expenditure may support AI infrastructure growth, while HKEX's listing data highlights funding trends in AI and robotics sectors.

RANK_REASON The cluster contains a major capital expenditure announcement from a large tech company and significant listing data from a major stock exchange for specialized tech firms. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Oracle CFO: Expecting Net Capital Expenditure of $70 Billion in Fiscal Year 2027, with Investment Returns Fully Guaranteed

    甲骨文首席财务官希拉里・芭芭拉・马克森周三在2026财年第四季度及全年财报电话会议上表示,2027财年,公司资本支出净现金流出预计为700亿美元。此外,本年度还将产生200亿至250亿美元的客户预付款及时间性差异金额,该部分不计入上述净现金流出。所有资本投入均依托已落地的客户长期合约(剩余履约义务),投资回报具备充分保障。(才是)